Stay updated on Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.

Latest updates to the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows an updated revision label (v3.5.3 instead of v3.5.2), indicating a minor site/package update rather than a change to the underlying study information.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision: v3.5.2 replaces v3.5.0.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check37 days agoChange DetectedVersion history updated with new entries for 2026-03-17, 2026-03, 2026-02-25, 2026-02 and Revision: v3.5.0. Older entries such as 2025-03-19, 2026-09, 2025-03-17, 2025-03 and Revision: v3.4.3 were removed.SummaryDifference0.3%

- Check45 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded Revision: v3.4.2 banner; removed the previous government-funding operating-status notice and Revision: v3.4.1.SummaryDifference0.4%

- Check80 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1, and a government funding/status notice was added to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.